John L. Brooks III
John L. Brooks III is President and Chief Executive Officer of Joslin Diabetes Center.
“I feel very passionately that Joslin has a singular ability to ultimately change the landscape of diabetes,” says Brooks. “With the diabetes pandemic that is exploding across the world, Joslin's excellence in research, clinical care, education and awareness is even more essential than ever. We have never been more focused in advancing this institution so we can continue to provide the right solutions in all aspects of diabetes.”
A well-known life sciences executive, Brooks assumed the President and Chief Executive Officer responsibilities in March 2011, having previously served as Chairman of the Joslin Board of Trustees.
Mr. Brooks co-founded three life sciences companies including Insulet, which offers an insulin-pump system for people with type 1 diabetes. He has been principal of Healthcare Capital Consulting LLC, which advises early-stage life sciences companies, and a founder of Prism VentureWorks, which raised more than $1.25 billion in capital. Brooks has been Chief Executive Officer of Reflectance Medical, which offers technology for non-invasive monitoring of critically ill patients.
He was also general manager at Pfizer/Valleylab, where he was responsible for Pfizer’s Hospital Products Group’s minimally invasive surgery and new medical technologies business. As President/General Manager at Pfizer/Strato, he led the growth of a rapidly evolving vascular access medical device business.
A native of Massachusetts, he holds an M.S. in Business and a B.B.A. cum laude from the University of Massachusetts at Amherst.
Page last updated: September 30, 2014